These data support a dominant protective role for CD@ ( + ) T-cell immunity in PHI compared with CD@ ( + ) T-cell responses , and are highly pertinent to HIV pathogenesis and vaccines , indicating that vaccine-induced CD@ ( + ) responses may confer sustained benefit .